GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Shares Outstanding (Diluted Average)

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Shares Outstanding (Diluted Average) : 14.99 Mil (As of Feb. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Shares Outstanding (Diluted Average)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's average diluted shares outstanding for the quarter that ended in Feb. 2024 was 14.99 Mil.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Shares Outstanding (Diluted Average) Historical Data

The historical data trend for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Shares Outstanding (Diluted Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Shares Outstanding (Diluted Average) Chart

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Shares Outstanding (Diluted Average)
Get a 7-Day Free Trial 14.35 14.96 14.91 15.04 14.91

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Semi-Annual Data
Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Shares Outstanding (Diluted Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 14.65 15.44 15.00 15.00 14.99

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Shares Outstanding (Diluted Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund  (NYSE:DCF) Shares Outstanding (Diluted Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Shares Outstanding (Diluted Average) Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Shares Outstanding (Diluted Average) provided by GuruFocus.com. Please click on the following links to see related term pages.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Traded in Other Exchanges
N/A
Address
c/o BNY Mellon Investment Adviser, Inc., 240 Greenwich Street, New York, NY, USA, 10286
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date.
Executives
Bushra Mannan other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang other: Dir. of Invest. Oversight (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak officer: President 200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella officer: VP C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein officer: VP 240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy officer: VP; Investment Adviser C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel other: Head of Finance of Sub-Adviser 200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc other: Sub-Adviser 200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson other: Portfolio Mgr of Sub-Adviser C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166